| Brandi Schnell, CRNA | |
|
1514 Jefferson Hwy, Jefferson, LA 70121-2429 | |
| (504) 842-3755 | |
| (504) 842-2036 |
| Full Name | Brandi Schnell |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 10 Years |
| Location | 1514 Jefferson Hwy, Jefferson, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063820926 | NPI | - | NPPES |
| 00651535 | Medicaid | MS | |
| 2371967 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | APO7886 (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Zephyr Anesthesia Llc | 1658559125 | 130 |
News Archive
The viruses that cause Ebola and Zika, daunting diseases that inspire concern at every outbreak, share a strong similarity in how they first infiltrate a host's cells. Through the computer modeling capabilities of Los Alamos National Laboratory, the molecular calisthenics involved in invading a cell are visually documented, an essential step toward vaccine and therapeutic medicine development.
Diverse antibodies induced in humans by vaccination with an avian influenza virus vaccine may offer broader, more durable protection against multiple strains of influenza than today's vaccines typically provide, according to a study led by Florian Krammer, PhD, Assistant Professor in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai, and Patrick Wilson, PhD, Associate Professor in the Department of Medicine at the University of Chicago.
A Commonwealth Fund survey also finds that 17 percent of those eligible for a marketplace plan have reached out online, on the phone or in person to get information, PoliticoPro reports. Other outlets look at news about state marketplaces.
Researchers analyzed data from the Traumatic Brain Injury Model System National Data and Statistical Center to study the contribution of race and ethnicity to retention of participants in TBI research.
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
› Verified 2 days ago
| Entity Name | Parish Anesthesia Ambulatory Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780872739 PECOS PAC ID: 3274622634 Enrollment ID: O20071207000657 |
News Archive
The viruses that cause Ebola and Zika, daunting diseases that inspire concern at every outbreak, share a strong similarity in how they first infiltrate a host's cells. Through the computer modeling capabilities of Los Alamos National Laboratory, the molecular calisthenics involved in invading a cell are visually documented, an essential step toward vaccine and therapeutic medicine development.
Diverse antibodies induced in humans by vaccination with an avian influenza virus vaccine may offer broader, more durable protection against multiple strains of influenza than today's vaccines typically provide, according to a study led by Florian Krammer, PhD, Assistant Professor in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai, and Patrick Wilson, PhD, Associate Professor in the Department of Medicine at the University of Chicago.
A Commonwealth Fund survey also finds that 17 percent of those eligible for a marketplace plan have reached out online, on the phone or in person to get information, PoliticoPro reports. Other outlets look at news about state marketplaces.
Researchers analyzed data from the Traumatic Brain Injury Model System National Data and Statistical Center to study the contribution of race and ethnicity to retention of participants in TBI research.
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
› Verified 2 days ago
| Entity Name | Parish Anesthesia Of Covington, L.l.c |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417145475 PECOS PAC ID: 8123117504 Enrollment ID: O20071207000805 |
News Archive
The viruses that cause Ebola and Zika, daunting diseases that inspire concern at every outbreak, share a strong similarity in how they first infiltrate a host's cells. Through the computer modeling capabilities of Los Alamos National Laboratory, the molecular calisthenics involved in invading a cell are visually documented, an essential step toward vaccine and therapeutic medicine development.
Diverse antibodies induced in humans by vaccination with an avian influenza virus vaccine may offer broader, more durable protection against multiple strains of influenza than today's vaccines typically provide, according to a study led by Florian Krammer, PhD, Assistant Professor in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai, and Patrick Wilson, PhD, Associate Professor in the Department of Medicine at the University of Chicago.
A Commonwealth Fund survey also finds that 17 percent of those eligible for a marketplace plan have reached out online, on the phone or in person to get information, PoliticoPro reports. Other outlets look at news about state marketplaces.
Researchers analyzed data from the Traumatic Brain Injury Model System National Data and Statistical Center to study the contribution of race and ethnicity to retention of participants in TBI research.
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
› Verified 2 days ago
| Entity Name | Parish Anesthesia Of Jefferson, L.l.c |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508054560 PECOS PAC ID: 6608965975 Enrollment ID: O20071210000390 |
News Archive
The viruses that cause Ebola and Zika, daunting diseases that inspire concern at every outbreak, share a strong similarity in how they first infiltrate a host's cells. Through the computer modeling capabilities of Los Alamos National Laboratory, the molecular calisthenics involved in invading a cell are visually documented, an essential step toward vaccine and therapeutic medicine development.
Diverse antibodies induced in humans by vaccination with an avian influenza virus vaccine may offer broader, more durable protection against multiple strains of influenza than today's vaccines typically provide, according to a study led by Florian Krammer, PhD, Assistant Professor in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai, and Patrick Wilson, PhD, Associate Professor in the Department of Medicine at the University of Chicago.
A Commonwealth Fund survey also finds that 17 percent of those eligible for a marketplace plan have reached out online, on the phone or in person to get information, PoliticoPro reports. Other outlets look at news about state marketplaces.
Researchers analyzed data from the Traumatic Brain Injury Model System National Data and Statistical Center to study the contribution of race and ethnicity to retention of participants in TBI research.
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
› Verified 2 days ago
| Entity Name | Parish Anesthesia Of Harvey Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487883823 PECOS PAC ID: 2961542014 Enrollment ID: O20091221000501 |
News Archive
The viruses that cause Ebola and Zika, daunting diseases that inspire concern at every outbreak, share a strong similarity in how they first infiltrate a host's cells. Through the computer modeling capabilities of Los Alamos National Laboratory, the molecular calisthenics involved in invading a cell are visually documented, an essential step toward vaccine and therapeutic medicine development.
Diverse antibodies induced in humans by vaccination with an avian influenza virus vaccine may offer broader, more durable protection against multiple strains of influenza than today's vaccines typically provide, according to a study led by Florian Krammer, PhD, Assistant Professor in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai, and Patrick Wilson, PhD, Associate Professor in the Department of Medicine at the University of Chicago.
A Commonwealth Fund survey also finds that 17 percent of those eligible for a marketplace plan have reached out online, on the phone or in person to get information, PoliticoPro reports. Other outlets look at news about state marketplaces.
Researchers analyzed data from the Traumatic Brain Injury Model System National Data and Statistical Center to study the contribution of race and ethnicity to retention of participants in TBI research.
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
› Verified 2 days ago
| Entity Name | Zephyr Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891087458 PECOS PAC ID: 1658559125 Enrollment ID: O20110705000180 |
News Archive
The viruses that cause Ebola and Zika, daunting diseases that inspire concern at every outbreak, share a strong similarity in how they first infiltrate a host's cells. Through the computer modeling capabilities of Los Alamos National Laboratory, the molecular calisthenics involved in invading a cell are visually documented, an essential step toward vaccine and therapeutic medicine development.
Diverse antibodies induced in humans by vaccination with an avian influenza virus vaccine may offer broader, more durable protection against multiple strains of influenza than today's vaccines typically provide, according to a study led by Florian Krammer, PhD, Assistant Professor in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai, and Patrick Wilson, PhD, Associate Professor in the Department of Medicine at the University of Chicago.
A Commonwealth Fund survey also finds that 17 percent of those eligible for a marketplace plan have reached out online, on the phone or in person to get information, PoliticoPro reports. Other outlets look at news about state marketplaces.
Researchers analyzed data from the Traumatic Brain Injury Model System National Data and Statistical Center to study the contribution of race and ethnicity to retention of participants in TBI research.
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
› Verified 2 days ago
| Entity Name | Galleria Anesthesia Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962966796 PECOS PAC ID: 6507261740 Enrollment ID: O20210825003473 |
News Archive
The viruses that cause Ebola and Zika, daunting diseases that inspire concern at every outbreak, share a strong similarity in how they first infiltrate a host's cells. Through the computer modeling capabilities of Los Alamos National Laboratory, the molecular calisthenics involved in invading a cell are visually documented, an essential step toward vaccine and therapeutic medicine development.
Diverse antibodies induced in humans by vaccination with an avian influenza virus vaccine may offer broader, more durable protection against multiple strains of influenza than today's vaccines typically provide, according to a study led by Florian Krammer, PhD, Assistant Professor in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai, and Patrick Wilson, PhD, Associate Professor in the Department of Medicine at the University of Chicago.
A Commonwealth Fund survey also finds that 17 percent of those eligible for a marketplace plan have reached out online, on the phone or in person to get information, PoliticoPro reports. Other outlets look at news about state marketplaces.
Researchers analyzed data from the Traumatic Brain Injury Model System National Data and Statistical Center to study the contribution of race and ethnicity to retention of participants in TBI research.
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brandi Schnell, CRNA 2525 Severn Ave, Metairie, LA 70002-5987 Ph: (504) 842-3755 | Brandi Schnell, CRNA 1514 Jefferson Hwy, Jefferson, LA 70121-2429 Ph: (504) 842-3755 |
News Archive
The viruses that cause Ebola and Zika, daunting diseases that inspire concern at every outbreak, share a strong similarity in how they first infiltrate a host's cells. Through the computer modeling capabilities of Los Alamos National Laboratory, the molecular calisthenics involved in invading a cell are visually documented, an essential step toward vaccine and therapeutic medicine development.
Diverse antibodies induced in humans by vaccination with an avian influenza virus vaccine may offer broader, more durable protection against multiple strains of influenza than today's vaccines typically provide, according to a study led by Florian Krammer, PhD, Assistant Professor in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai, and Patrick Wilson, PhD, Associate Professor in the Department of Medicine at the University of Chicago.
A Commonwealth Fund survey also finds that 17 percent of those eligible for a marketplace plan have reached out online, on the phone or in person to get information, PoliticoPro reports. Other outlets look at news about state marketplaces.
Researchers analyzed data from the Traumatic Brain Injury Model System National Data and Statistical Center to study the contribution of race and ethnicity to retention of participants in TBI research.
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
› Verified 2 days ago
Dr. Emily F Richard, DNP, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, Jefferson, LA 70121 Phone: 504-842-3000 | |
Mr. Lee Allen Dennis Jr., CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, Jefferson, LA 70121 Phone: 504-842-9119 | |
Andrew Larkin, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, Jefferson, LA 70121 Phone: 866-624-7637 | |
Dr. John Greer, DNP, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, Jefferson, LA 70121 Phone: 504-842-3000 | |
Rebecca Johnson Krobert, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, Jefferson, LA 70121 Phone: 504-842-3000 | |
Jenna Kelly, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, Jefferson, LA 70121 Phone: 504-842-3000 |